Novel immunologic assays now enable visualization of the antigen-specific r
esponse to an extent not previously possible. Assessment of not only the nu
meric frequency but also the functional properties of individual tumor-spec
ific T cells in the endogenous and manipulated immune response has provided
insights that will facilitate the development of immunotherapeutic strateg
ies.